CT SB00370 | 2019 | General Assembly

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 23 2019 - 25% progression, died in committee
Action: 2019-02-06 - Change of Reference, House to Committee on Insurance and Real Estate
Pending: Joint Insurance and Real Estate Committee
Text: Latest bill text (Introduced) [PDF]

Summary

To increase transparency in prescription drug pricing.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

An Act Establishing A Prescription Drug Review Board.

Sponsors


Roll Calls

2019-02-01 - Joint - PH Vote Tally Sheet (Y: 0 N: 0 NV: 0 Abs: 0) [PASS]

History

DateChamberAction
2019-02-06SenateChange of Reference, House to Committee on Insurance and Real Estate
2019-02-06SenateChange of Reference, Senate to Committee on Insurance and Real Estate
2019-02-01SenateChange of Reference Insurance and Real Estate
2019-01-23SenateReferred to Joint Committee on Public Health

Connecticut State Sources


Bill Comments

feedback